Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate Intravenous: Equivalence to Administration via Dialysate.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.1997
Abstract: Ferric pyrophosphate citrate (FPC) is indicated to maintain hemoglobin in chronic hemodialysis patients (CKD-5HD) by addition to the dialysate. An intravenous (IV) FPC presentation containing 6.75 mg iron in 4.5 mL was developed. The objective… read more here.
Keywords: fpc; equivalence; pyrophosphate citrate; post ... See more keywords
Ferric pyrophosphate citrate for parenteral administration of maintenance iron: structure, mechanism of action, clinical efficacy and safety
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2092373
Abstract: Abstract Anemia is a common complication in patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). Anemia is principally the result of erythropoietin deficiency, inflammation, and iron deficiency. High molecular weight iron oxide nanoparticles (IONP) are routinely… read more here.
Keywords: pyrophosphate citrate; iron; safety; ferric pyrophosphate ... See more keywords
Intestinal Absorption Study of a Granular Form of Ferric Pyrophosphate
Sign Up to like & getrecommendations! Published in 2022 at "Metabolites"
DOI: 10.3390/metabo12050463
Abstract: Iron deficiency is one of the most prevalent nutritional disorders worldwide. The standard treatment involves iron supplementation, but this task is challenging because of poor solubility and organoleptic issues. Moreover, the need to increase iron… read more here.
Keywords: ferric pyrophosphate; ferro fosfosoma; iron; intestinal absorption ... See more keywords